










































Prion-resistant or prion-susceptible species, this is the question
Citation for published version:
Chianini, F, Fernández-Borges, N, Eraña, H, Pang, Y, Vidal, E, Eaton, SL, Finlayson, J, Dagleish, MP &
Castilla, J 2013, 'Prion-resistant or prion-susceptible species, this is the question' Virulence, vol. 4, no. 4,
pp. 333-4. DOI: 10.4161/viru.24456
Digital Object Identifier (DOI):
10.4161/viru.24456
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright © 2013 Landes Bioscience
This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported
License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the
original source is properly cited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
www.landesbioscience.com Virulence 333
Virulence 4:4, 333–334; May 15, 2013; © 2013 Landes Bioscience
 NEWS NEWS & ViEWS
Previous in vivo studies left the scientific 
community with the assumption that rabbits 
were resistant to prion diseases. However, our 
recent findings proved they are susceptible. 
The in vitro results were essential to dem-
onstrate that prion protein (PrP) from every 
species has the potential to become not only 
misfolded to a disease associated form, but 
also capable of being virulent and causing 
clinical disease. Even though transmissible 
spongiform encephalopathies have only been 
described in mammals to date, it would not be 
too surprising if prion diseases could eventu-
ally be found in any class of animal that has PrP 
such as birds, reptiles or fish.
The first reported observations of a trans-
missible spongiform encephalopathy (TSE) in 
Europe were in the first half of the 18th century 
when Thomas Comber described a disease of 
sheep, originally called rickets, which we know 
today as scrapie. However, the ability of TSEs 
to transmit to other species was unknown 
until 1960–1970 when the first experimental 
infections were performed in mice and other 
laboratory animals.
The differences between TSEs and other 
contagious diseases were evident early on, 
starting with the unusual characteristics of 
their pathogenesis, their unknown origin and 
especially their ability to be transmitted exper-
imentally to a large number of species, even 
though different species are not equally sus-
ceptible (Barlow et al., Res Vet Sci 1976).
in the 1990s and early 21st century the 
main aim of TSE research was to establish the 
etiological agent, and although accomplish-
ing this objective was of fundamental impor-
tance, it required most of the available funding 
resources and thereby prevented investiga-
tions of other aspects of these diseases.
Whereas confirmation of the “protein only 
hypothesis” represented a significant step 
forward for TSE science, it made the strain 
phenomenon and transmissibility between 
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species more difficult to explain. Undoubtedly, 
it would have been easier to explain TSEs if the 
etiological agent was a virus or a bacterium, 
instead of one whose principal or only compo-
nent is a protein.
in the past, many experimental infections 
were performed using different sources of 
TSEs, both within and between species, in an 
attempt to understand their pathogeneses 
and transmissibilities. However, in many occa-
sions the existence of different strains was 
ignored.
The appearance of bovine spongiform 
encephalopathy (BSE) advanced knowledge 
in this area as a large number of animals were 
accidentally exposed to a novel TSE agent 
(Bons et al., Proc Natl Acad Sci U S A 1999). 
This “unplanned experiment” also showed that 
not every species was equally susceptible. For 
example, BSE was found in the goat popula-
tion in the UK and France, but no cases were 
reported in pigs, despite proven experimen-
tal susceptibility, and having been naturally 
exposed to the agent during the BSE out-
break. However, we should not generalize 
with respect to susceptibility to prion diseases 
as their behaviors, and possibly even their 
mechanisms, can be as numerous as the num-
ber of identified strains. Without knowledge 
of the intrinsic characteristic of strains, the 
observation of natural and experimental infec-
tions may lead us to think that every strain 
is a unique and independent agent. This is 
because, despite having several similar char-
acteristics, sometimes the different TSE strains 
behave as differently as the influenza virus 
does from the hepatitis C viruses. For example, 
different TSE strains target different species 
and tissues, with different incubation times 
and result in different clinical manifestations. 
Due to these innate differences, predicting 
if a strain will transmit to another species is 
very difficult and suggesting that a disease 
associated prion protein generated in cows 
either can or cannot transmit to humans is 
also dangerous. At best, we can try estimating 
the zoonotic potential of animal prions with 
ad hoc models such as primates or human 
PrP transgenic mice. Furthermore, it is cur-
rently impossible to establish if and how these 
unconventional agents will adapt and mutate 
when they infect new species. For all these 
reasons it is ill-advised to define a species 
as resistant to prion diseases on the basis of 
absence of natural cases or experiments where 
one can only use a limited number of strains.
The degree of pathogenicity of differ-
ent disease associated prions, or virulence, 
is determined by the incidence of infection 
and the length of time between exposure and 
development of clinical signs. These data allow 
the classification of prion diseases from low to 
high virulence, but only if related to a specific 
species. This is because a TSE which is highly 
virulent in one species can be of low virulence 
or even avirulent in another. This paradigm 
of transmission is influenced by both the TSE 
strain and the species it is infecting, therefore, 
it is possible that every species has a specific 
strain that, once adapted, would represent the 
most virulent disease associated prion in that 
species.
The route of infection in TSEs plays a critical 
role in transmissibility and also the capacity 
of prions to replicate extraneurally is strain-
specific (Beringue et al., Science 2012). This 
is often also responsible for the virulence of 
a strain in the same species. An exceptional 
example of transmissibility is scrapie, which, 
despite having been recognized for centuries 
as being highly virulent in sheep and goats, 
has never been reported as a natural infection 
in any other species and is therefore consid-
ered avirulent in humans. However, no one 
can be totally sure about its ability to adapt to 
other species. With respect to this it is impor-
tant to mention that when BSE has been trans-
mitted to sheep it becomes more virulent on 
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re-passage as denoted by shorter incubation 
times in cattle and by an increase in the num-
ber of species it is capable of infecting (Padilla 
et al., PLoS Pathog 2011). These changes could 
happen with other TSE strains.
it is interesting to consider the poten-
tial virulence in common domestic species 
in which spontaneous prion diseases have 
never been reported. We should be very cau-
tious in predicting the behavior of TSEs in 
these animals as transmissibility will depend 
on the combination of strain and challenged 
species. Nevertheless one should not consider 
this area of research an unanswerable enigma 
unless all strains are tested in every species, as 
this is unrealistic. To resolve this situation and 
start addressing some of these questions we 
have used our expertise in the in vitro repli-
cation of prions (Castilla et al., Cell 2005). We 
have examined a large number of TSE strains/
challenge species transmission combinations 
and performed a two passage study on the 
susceptibility of rabbits to in vitro generated 
homologous species disease associated prion 
infection (Chianini et al., Proc Natl Acad Sci 
U  S  A 2012). Prior to this study there were 
many uncertainties with respect to the sus-
ceptibility of rabbits to TSEs; previous in vivo 
studies had failed to transmit the disease yet 
the success of our in vitro studies proved that 
rabbit PrP could be efficiently misfolded after 
being seeded with different prion strains from 
different species and even formed an infec-
tious de novo strain from unseeded brain.
The results of the in vivo studies left the 
scientific community with the assumption 
that rabbits were resistant to prion diseases. 
However, our recent findings proved they are 
susceptible. The in vitro results were essential 
to demonstrate that PrP from every species 
has the potential to become not only mis-
folded to a disease associated form, but also 
capable of being virulent and causing clini-
cal disease. in our case rabbit PrP misfolded 
in vitro and produced a de novo protease-
resistant PrP from a healthy rabbit brain. This 
de novo PrP was capable of infecting a small 
percentage of rabbits on primary passage but 
a very high percentage succumbed to clinical 
disease upon second passage. Although with 
respect to our definition of virulence we could 
not consider our strain to be highly virulent; 
the mean for the incubation time was around 
550 d post infection, we should not forget that 
several factors can influence the incubation 
time without altering the virulence. A clear 
example of this would be the long incubation 
times associated with human TSE strains in 
human infections, which are highly virulent.
From the production of the de novo TSE 
strain derived from the brain of a healthy rab-
bit it is tempting to speculate that its formation 
may be comparable to the spontaneous forms 
of prion disease, called atypical, and reported 
in humans and ruminants. These forms of prion 
diseases have always proven to be efficiently 
transmitted to the homologous species.
Even though we demonstrated that rab-
bits are not resistant to prion diseases, the 
studies performed in vivo previously and then 
confirmed with our study, showed that this 
species is not susceptible to TSE strains com-
monly virulent in other species such as ME7 in 
mice. These findings highlight the importance 
of the compatibility between the infectious 
PrP and the native PrP of the challenged spe-
cies. This compatibility is dependent upon 
the amino acid sequence of the PrP and dif-
ferences between the two proteins can deter-
mine the success or not of replication of the 
disease associated form.
Unfortunately, a simple comparison of PrP 
amino acid sequences between the species 
where strains have originated and the ones 
which are to be investigated cannot deter-
mine which PrP amino acids are responsible 
for successful disease transmission. This is not 
surprising since different strains with a dif-
ferent clinical course can be raised from the 
same species which has the same PrP amino 
acid sequence. To make things more complex, 
intermediate hosts can change the ability of 
certain prion diseases to become infectious 
in a species that otherwise appears not to be 
susceptible. The mechanism of how this hap-
pens is unclear, but the intermediate host may 
induce a conformational change or a mutation 
in the disease associated PrP strain or just aid 
the infectious ability of this strain in a different 
PrP environment. Therefore, thanks to inter-
mediate hosts, certain TSE strains can increase 
their virulence and spread to other species 
as happened for BSE transmitted to sheep as 
previously explained.
in conclusion, even though TSEs have only 
been described in mammals to date, it would 
not be too surprising if, given the chance to 
evolve through intermediate hosts, prion dis-
eases could eventually be found in any class 
of animal that has PrP such as birds, reptiles 
or fish.
